Coronavirus (COVID-19)

This page contains medical information for clinicians on the 2019 Novel Coronavirus (COVID-19, also called 2019-nCoV, and now clinically SARS‐CoV‐2). This section includes articles that pertain to clinicians and cardiologists on the virus, new technologies being deployed to fight the virus and clinical information from various sources. Here are direct links for medical professionals to COVID-19 resources from the U.S. Food and Drug Administration (FDA)Centers for Disease Control (CDC) and the World Health Organization (WHO). Daily world-wide statistics on the coronavirus outbreak are available from the WHO Situations Reports. Here is the Centers for Medicare and Medicaid Services (CMS) frequently asked questions and answers (FAQs) for healthcare providers regarding Medicare payment for laboratory tests and other services related to the COVID-19.

Bilateral pulmonary embolisms seen on spectral CT. Photo courtesy of Siemens Healthineers.
Feature | Coronavirus (COVID-19)

May 4, 2020 — A committee comprised of vascular surgeons, medical physicians and technologists from the University of ...

Home May 04, 2020
Home
News | ECG Wireless Remote Access

May 4, 2020 — Cardiac Insight Inc., a U.S.-based digital healthcare innovator specializing in body-worn sensor ...

Home May 04, 2020
Home
Videos | Coronavirus (COVID-19)

Thomas Maddox, M.D., MSc, FACC, the chair of the American College of Cardiology (ACC) Science and Quality Committee ...

Home May 01, 2020
Home
News | EP Lab

May 1, 2020 — The Heart Rhythm Society (HRS) has created a COVID-19 Task Force to make recommendations related to ...

Home April 30, 2020
Home
News | Coronavirus (COVID-19)

April 23, 2020 — A special report published in the journal Radiology outlines prevention, diagnosis and treatment of ...

Home April 30, 2020
Home
There have been several safety reports to the FDA that COVID-19 patients receiving hydroxychloroquine and chloroquine, either aloneaths and Injuries From Use of Antimalarial Drugs in COVID-19 Patients. he U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication today reminding doctors there are serious side effects when using hydroxychloroquine and chloroquine in the off-lable use to treat COVID-19 patients. This includes potentially life-threatening heart rhythms. #COVID19 #SARScov2
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

April 23, 2020 — The U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication today reminding doctors ...

Home April 24, 2020
Home
News | Coronavirus (COVID-19)

April 23, 2020 – LivaNova PLC said the U.S. Food and Drug Administration (FDA) is now permitting the company to expand ...

Home April 23, 2020
Home
SCAI, ACC and ACEP release consensus document on how to manage acute myocardial infarctions during the SARS-C0V-2 outbreak, #COVIF19 #coronavirus
Feature | Cath Lab
Home April 22, 2020
Home
Videos | Coronavirus (COVID-19)

Justin Fried, M.D., Attending cardiologist at Columbia University Irving Medical Center, New York City, and assistant ...

Home April 22, 2020
Home
News | Coronavirus (COVID-19) | Dave Fornell, Editor

April 20, 2020 — As the United States continues to face the unprecedented public health emergency from the COVID-19 ...

Home April 20, 2020
Home
Videos | Coronavirus (COVID-19)

Stephen Bloom, M.D., FASNC, director of nonivasive cardiology (cardiac CT, nuclear cardiology and echocardiography) at M ...

Home April 18, 2020
Home
Cardiac Imaging Best Practices During the COVID-19 Pandemic. Cardiology imaging societies issue guidelines on how to handle patient imaging under virus precautions. #COVID19 #SARScov2
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

Cases of acute cardiovascular disease and cardiac complications caused by COVID-19 require cardiovascular imaging ...

Home April 18, 2020
Home
Videos | Coronavirus (COVID-19)

DAIC Editor Dave Fornell has conducted numerous video interviews remotely from his home office in March and April 2020 ...

Home April 17, 2020
Home
ASE issued guidelines for the protection of echocardiography providers during the COVID-19 outbreak. Image shows a Philips Ultrasound system being used during a demonstration at the ASE 2019 meeting. #SARScov2
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

The provision of echocardiographic services remains crucial during the novel coronavirus (COVID-19, SARS-CoV-2) outbreak ...

Home April 14, 2020
Home
Subscribe Now